Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study
Protein tyrosine phosphatase 1B (PTP1B) plays a specific role as a negative regulator of insulin signaling pathways and is a validated therapeutic target for Type 2 diabetes. Previously, arylbenzofurans were reported to have inhibitory activity against PTP1B. However, detailed investigation regardin...
Main Authors: | Srijan Shrestha, Su Hui Seong, Seul Gi Park, Byung Sun Min, Hyun Ah Jung, Jae Sue Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/16/2893 |
Similar Items
-
Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity
by: Ericsson Coy-Barrera
Published: (2020-01-01) -
New 2-Arylbenzofurans from the Root Bark of Artocarpus lakoocha
by: Boonchoo Sritularak, et al.
Published: (2010-09-01) -
Dithiocarbamates as potential PTP1B inhibitors for diabetes management
by: Tanvi A. Deshpande, et al.
Published: (2022-01-01) -
Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents
by: Yinling Yun, et al.
Published: (2021-01-01) -
In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf
by: Katherine Olabanjo Olufolabo, et al.
Published: (2024-02-01)